Loss of RASSF2 Enhances Tumorigencity of Lung Cancer Cells and Confers Resistance to Chemotherapy

Jennifer Clark(Roswell Park Comprehensive Cancer Center), Howard Donninger(University of Louisville)
Molecular Biology International
May 24, 2012
Cited by 22


Related Papers